OpenScience.ink

1 week ago • Heart rhythm

Risk of Irregular Heartbeats Linked to Drugs That Activate Glucagon-Like Peptide-1 Receptors: A Comparative AnalysisGlucagon-Like Peptide-1 Receptor Agonists and Risk of Arrhythmias: A Network Meta-Analysis.

🥉 Top 5% JournalArticle

1 week ago • Hand (New York, N.Y.)

Use of a Blood Sugar Drug Linked to More Nerve Pressure Problems After Weight Loss SurgeryGlucagon-Like Peptide-1 Receptor Agonist Use Is Associated With Increased Peripheral Nerve Compression After Bariatric Surgery.

📖 Top 30% JournalArticle

1 week ago • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Cell-Based Treatments Using Supportive Tissue Cells for Metabolic Problems Linked to Obesity: How They Work, Evidence for Use, and Future DirectionsMesenchymal stromal cell-based therapies for obesity-associated metabolic complications: Mechanistic insights, translational evidence, and future perspectives.

🎖️ Top 10% JournalArticle

1 week ago • Cell metabolism

UBT251, a new drug targeting three hormone receptors, tested in adults with type 2 diabetes in a multi-site phase 2 trialUBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with type 2 diabetes: A multicenter, randomized phase 2 trial.

🥇 Top 1% JournalArticle

1 week ago • Advances in therapy

Who Uses Tirzepatide for Type 2 Diabetes in Germany and How They Are TreatedCharacteristics and Treatment Utilisation Patterns of Individuals Using Tirzepatide for Type 2 Diabetes in Germany.

📖 Top 20% JournalArticle

1 week ago • Breast cancer research and treatment

Weight loss linked to GLP-1 receptor drugs in breast cancer patients receiving hormone therapyGLP-1 receptor agonist-associated weight loss in breast cancer patients receiving concurrent endocrine therapy: a retrospective cohort analysis.

🎖️ Top 10% JournalArticle

1 week ago • The British journal of psychiatry : the journal of mental science

Changes in metabolic markers before and after starting GLP-1 receptor treatment in people with schizophreniaMetabolic biomarker levels before and after initiation of GLP-1 receptor agonist treatment among individuals with schizophrenia: interrupted time-series analysis.

🥉 Top 5% JournalArticle

1 week ago • European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Effectiveness and safety of diabetes drugs for people with schizophrenia on antipsychotic treatmentEfficacy and safety of GLP-1 receptor agonists in patients with schizophrenia spectrum disorders treated with antipsychotics: a systematic review and meta-analysis.

🥉 Top 5% JournalArticle

1 week ago • Journal of diabetes investigation

Poor Parasympathetic Function Measured by Deep Breathing Linked to Early Stopping of Oral Semaglutide in Type 2 DiabetesParasympathetic dysfunction assessed by deep-breathing CVR-R is associated with early discontinuation of oral semaglutide in type 2 diabetes: A multicenter retrospective study.

📖 Top 20% JournalArticle

1 week ago • ACS nano

Intestinal Immune Cells Package Peptides in Tiny Carriers to Create Long-Lasting Oral TreatmentsIntestinal Macrophage-Mediated Exosomal Repackaging Establishes Bioactive Reservoirs for Long-Acting Oral Peptide Therapy.

🥈 Top 2% JournalArticle

1 week ago • Obesity pillars

One-year weight loss patterns and factors linked to response with personalized tirzepatide dosing in real-world settings12-month weight-loss trajectories and predictors of response to tirzepatide under individualized dosing: A multicenter real-world study.

📖 Top 20% JournalArticle

1 week ago • European journal of pediatrics

Treating childhood fatty liver disease by targeting the gut-liver connection and gut bacteria: current knowledge and future optionsTargeting the gut-liver axis and gut microbiome in pediatric metabolic dysfunction-associated steatotic liver disease: current evidence and future directions.

📖 Top 20% JournalArticle

1 week ago • Annals of hepatology

Current treatments and challenges for fatty liver disease linked to metabolismPharmacotherapy for MASLD: current evidence and challenges in clinical practice.

📖 Top 20% JournalArticle

1 week ago • Annual review of physiology

New Developments in Treatments Using Incretin HormonesNew Horizons for Incretin-Based Therapeutics.

🥇 Top 1% JournalArticle

1 week ago • Journal of proteome research

Semaglutide and Tirzepatide reduce liver fat absorption and fat breakdown in obese mice fed a high-fat dietSemaglutide and Tirzepatide Suppress Hepatic Fatty Acid Uptake and Fatty Acid β-Oxidation in High-Fat Diet-Induced Obesity Mice.

📖 Top 20% JournalArticle

1 week ago • GeroScience

What dog lifespan treatments can teach us about human healthLessons from dog lifespan therapeutics for their human companions.

🎖️ Top 10% JournalArticle

1 week ago • Journal of medical Internet research

Widespread GLP-1 Antibodies and Their Impact on Body Weight RegulationGLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?

🥉 Top 5% JournalArticle

1 week ago • Journal of medicinal chemistry

Oral Small-Molecule Drugs That Activate GLP-1 Receptors: Insights from Clinical Trials and Guidelines for Future DevelopmentOral Small-Molecule GLP-1 Receptor Agonists: Lessons from Clinical Candidates and a Blueprint for Next-Generation Design.

🎖️ Top 10% JournalArticle

1 week ago • EClinicalMedicine

Weight loss and blood pressure changes with GLP-1 and multi-hormone drugs in overweight and obese adultsWeight loss and blood pressure lowering with GLP-1 receptor agonists and multi-hormone receptor modulators in overweight and obesity: a systematic review and meta-regression of phase 3 clinical trials.

🥈 Top 2% JournalArticle

1 week ago • Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

Comparing weight-loss surgery and diabetes drugs in dialysis patients with obesity and diabetesMetabolic bariatric surgery versus GLP-1 receptor agonists in dialysis patients with diabetes and obesity: a target trial emulation study.

📖 Top 20% JournalArticle

1 week ago • The American journal of medicine

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Lung and Digestive Problems After Anesthesia in a Large International StudyThe Impact of Glucagon-Like Peptide-1 Receptor Agonists on Post-Anesthetic Pulmonary and Gastrointestinal Adverse Events: A Target Trial Emulation Using Multinational Database.

📖 Top 20% JournalArticle

1 week ago • Current obesity reports

Understanding the Safety of GLP-1 Receptor Agonists: Facts, Myths, and Current DebatesDecoding the Safety Profile of GLP-1 Receptor Agonists: Facts, Myths, and Ongoing Controversies.

🥉 Top 5% JournalArticle

1 week ago • EClinicalMedicine

Cardiorenal trials should report absolute risk reduction and number needed to treat, not just relative risk reductionRelative risk reduction is not enough: why cardiorenal trials should routinely report absolute risk reduction and number needed to treat.

🥈 Top 2% JournalArticle

1 week ago • Diabetology & metabolic syndrome

Ecnoglutide's safety and treatment effects for type 2 diabetes: a review and combined analysisEvaluating the therapeutic benefits and safety of ecnoglutide for type 2 diabetes: evidence from a systematic review and meta-analysis.

📖 Top 20% JournalArticle

1 week ago • The spine journal : official journal of the North American Spine Society

Recovery after Neck Spine Surgery in Type 2 Diabetes Patients Using Diabetes Drugs versus Weight-Loss SurgeryOutcomes after Posterior Cervical Spine Surgery: A Matched Cohort Analysis and Comparison of GLP-1 Receptor Agonist Use and Bariatric Surgery in Patients with Type 2 Diabetes.

🥉 Top 5% JournalArticle

1 week ago • Endocrinology and metabolism clinics of North America

How GLP-1 Receptor Agonists May Affect Contraception, Fertility, and PregnancyGLP-1 Receptor Agonists and Reproductive Health: Implications for Contraception, Fertility, and Pregnancy.

🎖️ Top 10% JournalArticle

1 week ago • International journal of pharmaceutics

Dissolving microneedles for skin delivery of semaglutide to reduce obesity in ratsPoly(vinyl alcohol) dissolving microneedles for transdermal semaglutide delivery and anti-obesity therapy in rats.

📖 Top 20% JournalArticle

1 week ago • The New England journal of medicine

Weekly Retatrutide Treatment for Obstructive Sleep ApneaRetatrutide Once Weekly for Treatment of Obstructive Sleep Apnea.

🏆 Top 0.1% JournalArticle

1 week ago • Endocrinology and metabolism (Seoul, Korea)

Temporary Fat Tissue Inflammation Changes During Rapid Weight Loss and Regain Caused by High-Dose SemaglutideTransient Adipose Inflammatory Remodeling during High-Dose Semaglutide-Induced Weight Loss and Regain.

🎖️ Top 10% JournalArticle

1 week ago • Reviews in endocrine & metabolic disorders

GIP signaling in belly and under-skin fat: possible links to obesity and metabolic diseaseGlucose-dependent insulinotropic polypeptide (GIP) signaling in visceral and subcutaneous adipose tissue: implications for obesity and metabolic disease-a narrative review with a structured literature search.

🥉 Top 5% JournalArticle

← prevpage 7 of 16next →

GLP-1 Therapies Research Papers